Literature DB >> 10460585

The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance.

J R Downing1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10460585     DOI： 10.1046/j.1365-2141.1999.01377.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  37 in total

1.  Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.

Authors:  Guy J Leclerc; Christopher Sanderson; Stephen Hunger; Meenakshi Devidas; Julio C Barredo
Journal:  Leuk Res       Date:  2010-06-09       Impact factor: 3.156

2.  Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.

Authors:  T Okuda; K Takeda; Y Fujita; M Nishimura; S Yagyu; M Yoshida; S Akira; J R Downing; T Abe
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

4.  ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes.

Authors:  Daniela Salat; Robert Liefke; Jörg Wiedenmann; Tilman Borggrefe; Franz Oswald
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

Review 5.  Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights.

Authors:  Nicholas R Harrison; Fabrice J F Laroche; Alejandro Gutierrez; Hui Feng
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

6.  Chaperonin TRiC/CCT Recognizes Fusion Oncoprotein AML1-ETO through Subunit-Specific Interactions.

Authors:  Soung-Hun Roh; Moses M Kasembeli; Jesús G Galaz-Montoya; Wah Chiu; David J Tweardy
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

7.  Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.

Authors:  Stephen M Wiesner; Jennifer L Geurts; Miechaleen D Diers; Rachel J Bergerson; Diane E Hasz; Kelly J Morgan; David A Largaespada
Journal:  Am J Hematol       Date:  2011-07       Impact factor: 10.047

Review 8.  Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

Authors:  Kelly Faulk; Lia Gore; Todd Cooper
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

9.  Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.

Authors:  Cristina G de Guzman; Alan J Warren; Zheng Zhang; Larry Gartland; Paul Erickson; Harry Drabkin; Scott W Hiebert; Christopher A Klug
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice.

Authors:  Timothy S Fenske; Gina Pengue; Vikram Mathews; Piia T Hanson; Sarah E Hamm; Noor Riaz; Timothy A Graubert
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.